NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $126,000 | -15.4% | 6,550 | +11.1% | 0.00% | – |
Q2 2023 | $149,000 | +13.7% | 5,893 | +63.0% | 0.00% | – |
Q1 2023 | $131,000 | -45.4% | 3,615 | -40.4% | 0.00% | – |
Q4 2022 | $240,000 | +179.1% | 6,065 | +227.1% | 0.00% | – |
Q3 2022 | $86,000 | +14.7% | 1,854 | +10.0% | 0.00% | – |
Q2 2022 | $75,000 | -71.2% | 1,686 | -53.2% | 0.00% | – |
Q1 2022 | $260,000 | -63.0% | 3,602 | -58.5% | 0.00% | – |
Q4 2021 | $703,000 | +11.1% | 8,675 | +59.5% | 0.00% | – |
Q3 2021 | $633,000 | -82.7% | 5,440 | -75.4% | 0.00% | -100.0% |
Q2 2021 | $3,663,000 | +26.5% | 22,097 | +6.4% | 0.00% | 0.0% |
Q1 2021 | $2,896,000 | -9.6% | 20,764 | +12.2% | 0.00% | 0.0% |
Q4 2020 | $3,202,000 | +45.0% | 18,500 | +16.7% | 0.00% | 0.0% |
Q3 2020 | $2,209,000 | +21.6% | 15,859 | +4.2% | 0.00% | 0.0% |
Q2 2020 | $1,817,000 | +38.7% | 15,215 | +16.1% | 0.00% | 0.0% |
Q1 2020 | $1,310,000 | -9.7% | 13,107 | +6.2% | 0.00% | 0.0% |
Q4 2019 | $1,450,000 | +71.8% | 12,338 | +25.6% | 0.00% | – |
Q3 2019 | $844,000 | +3146.2% | 9,825 | +2344.0% | 0.00% | – |
Q2 2019 | $26,000 | +13.0% | 402 | +11.0% | 0.00% | – |
Q1 2019 | $23,000 | -45.2% | 362 | -66.8% | 0.00% | – |
Q4 2018 | $42,000 | -91.4% | 1,091 | -87.3% | 0.00% | – |
Q3 2018 | $488,000 | -7.6% | 8,569 | +29.6% | 0.00% | – |
Q2 2018 | $528,000 | -20.7% | 6,610 | -14.2% | 0.00% | – |
Q1 2018 | $666,000 | +106.8% | 7,702 | +65.0% | 0.00% | – |
Q4 2017 | $322,000 | -97.6% | 4,667 | -96.8% | 0.00% | -100.0% |
Q3 2017 | $13,303,000 | -21.8% | 146,392 | -36.0% | 0.01% | -33.3% |
Q2 2017 | $17,022,000 | -11.2% | 228,687 | +11.8% | 0.01% | -10.0% |
Q1 2017 | $19,169,000 | -15.9% | 204,586 | -34.8% | 0.01% | -16.7% |
Q4 2016 | $22,792,000 | +2.8% | 313,674 | +47.7% | 0.01% | -7.7% |
Q3 2016 | $22,170,000 | +4.5% | 212,379 | -26.1% | 0.01% | 0.0% |
Q2 2016 | $21,210,000 | +51.3% | 287,555 | +15.4% | 0.01% | +44.4% |
Q1 2016 | $14,022,000 | +1402100.0% | 249,246 | +1246130.0% | 0.01% | – |
Q4 2015 | $1,000 | -97.1% | 20 | -97.4% | 0.00% | – |
Q3 2015 | $35,000 | -22.2% | 760 | -8.8% | 0.00% | – |
Q2 2015 | $45,000 | +1400.0% | 833 | +1125.0% | 0.00% | – |
Q4 2014 | $3,000 | – | 68 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |